Open Market Insiders Trades
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- P - Open market or private purchase of non-derivative or derivative security
- S - Open market or private sale of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
HD
|
William G. Lennie
Executive Vice President |
SELL
Open market or private sale
|
Direct | 31,239 Reduced 40.29% |
$4,856,727
$155.47 p/Share
|
May 18
2017 |
|
ABBV
|
William J Chase
EVP, Finance & Administration |
SELL
Open market or private sale
|
Direct | 38,300 Reduced 17.26% |
$2,502,905
$65.35 p/Share
|
May 18
2017 |
|
NEE
|
James L Robo
Director |
SELL
Open market or private sale
|
Direct | 52,320 Reduced 13.69% |
$7,153,190
$136.72 p/Share
|
May 18
2017 |
|
PFGC
|
Blackstone Holdings Iii L.P.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 13,700,465 Reduced 99.45% |
$375,529,744
$27.41 p/Share
|
May 18
2017 |
|
NVDA
|
Persis Drell
Director |
SELL
Open market or private sale
|
Direct | 2,500 Reduced 9.21% |
$325,050
$130.02 p/Share
|
May 18
2017 |
|
RARX
|
Novartis Bioventures LTD
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 9,019 Reduced 0.37% |
$229,984
$25.5 p/Share
|
May 18
2017 |
|
AMT
|
David E Sharbutt |
SELL
Open market or private sale
|
Direct | 3,653 Reduced 36.18% |
$469,812
$128.61 p/Share
|
May 18
2017 |
|
CRSP
|
Rodger Novak
President |
SELL
Open market or private sale
|
Direct | 25,923 Reduced 2.09% |
$415,546
$16.03 p/Share
|
May 17
2017 |
|
RARX
|
Novartis Bioventures LTD
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 22,534 Reduced 0.92% |
$574,842
$25.51 p/Share
|
May 17
2017 |
|
MDC
|
Herbert T Buchwald
Director |
SELL
Open market or private sale
|
Direct | 26,250 Reduced 100.0% |
$896,175
$34.14 p/Share
|
May 17
2017 |
|
ARE
|
Stephen Richardson
Co-Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 7,500 Reduced 6.47% |
$881,325
$117.51 p/Share
|
May 17
2017 |
|
EA
|
Patrick Soderlund
Chief Design Officer |
SELL
Open market or private sale
|
Direct | 55,163 Reduced 24.73% |
$5,928,368
$107.47 p/Share
|
May 17
2017 |
|
HD
|
Craig A Menear
Chair |
SELL
Open market or private sale
|
Direct | 90,661 Reduced 37.76% |
$14,214,738
$156.79 p/Share
|
May 17
2017 |
|
HD
|
Teresa Wynn Roseborough
EVP, Gen. Counsel & Corp. Sec. |
SELL
Open market or private sale
|
Direct | 29,076 Reduced 51.01% |
$4,567,549
$157.09 p/Share
|
May 17
2017 |
|
HD
|
Mark Holifield
EVP-Supply Chain & Product Dev |
SELL
Open market or private sale
|
Direct | 48,769 Reduced 59.66% |
$7,649,418
$156.85 p/Share
|
May 17
2017 |
|
HD
|
Matt Carey
EVP |
SELL
Open market or private sale
|
Direct | 14,680 Reduced 22.08% |
$2,304,907
$157.01 p/Share
|
May 17
2017 |
|
HD
|
Ann Marie Campbell
Senior EVP |
SELL
Open market or private sale
|
Direct | 7,000 Reduced 11.46% |
$1,095,920
$156.56 p/Share
|
May 17
2017 |
|
LSXMA
|
Berkshire Hathaway Inc |
BUY
Open market or private purchase
|
Indirect | 580,907 Added 1.96% |
$21,075,305
$36.28 p/Share
|
May 17
2017 |
|
LSXMA
|
Berkshire Hathaway Inc |
BUY
Open market or private purchase
|
Indirect | 100,071 Added 0.73% |
$3,647,588
$36.45 p/Share
|
May 17
2017 |
|
HD
|
Wayne M. Hewett
Director |
BUY
Open market or private purchase
|
Direct | 350 Added 20.0% |
$54,989
$157.11 p/Share
|
May 17
2017 |
|
VYNT
|
Geoffrey E. Harris
Director |
BUY
Open market or private purchase
|
Direct | 2,500 Added 10.0% |
$9,375
$3.75 p/Share
|
May 16
2017 |
|
LSXMA
|
Berkshire Hathaway Inc |
BUY
Open market or private purchase
|
Indirect | 315,000 Added 1.09% |
$11,529,000
$36.6 p/Share
|
May 16
2017 |
|
LSXMA
|
Berkshire Hathaway Inc |
BUY
Open market or private purchase
|
Indirect | 142,065 Added 1.04% |
$5,227,992
$36.8 p/Share
|
May 16
2017 |
|
VYNT
|
John Pappajohn
Director |
BUY
Open market or private purchase
|
Direct | 19,310 Added 0.79% |
$73,378
$3.8 p/Share
|
May 16
2017 |
|
EVRI
|
Eileen F Raney
Director |
BUY
Open market or private purchase
|
Direct | 14,000 Added 21.88% |
$94,220
$6.73 p/Share
|
May 16
2017 |
|
IBM
|
James W Owens |
BUY
Open market or private purchase
|
Indirect | 1,718 Added 25.57% |
$263,180
$153.19 p/Share
|
May 16
2017 |
|
OLED
|
Sidney D Rosenblatt |
BUY
Open market or private purchase
|
Indirect | 140 Added 0.0% |
$16,413
$117.24 p/Share
|
May 16
2017 |
|
TRU
|
Gerald M Mc Carthy Jr
EVP - Healthcare |
SELL
Open market or private sale
|
Direct | 73,500 Reduced 71.66% |
$3,063,480
$41.68 p/Share
|
May 16
2017 |
|
TRU
|
John W Blenke
EVP, Corp GC & Asst Secretary |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 8.02% |
$418,200
$41.82 p/Share
|
May 16
2017 |
|
MDC
|
Michael Touff
Sr VP and General Counsel |
SELL
Open market or private sale
|
Direct | 84,000 Reduced 41.89% |
$2,889,600
$34.4 p/Share
|
May 16
2017 |
|
SQ
|
Jack Dorsey
Block Head and Chairperson |
SELL
Open market or private sale
|
Indirect | 381,500 Reduced 100.0% |
$7,790,230
$20.42 p/Share
|
May 16
2017 |
|
CRSP
|
Rodger Novak
President |
SELL
Open market or private sale
|
Direct | 24,077 Reduced 1.94% |
$397,270
$16.5 p/Share
|
May 16
2017 |
|
PLXS
|
Michael V Schrock
Director |
SELL
Open market or private sale
|
Direct | 5,000 Reduced 16.23% |
$256,850
$51.37 p/Share
|
May 16
2017 |
|
AAPL
|
Daniel J. Riccio
Senior Vice President |
SELL
Open market or private sale
|
Direct | 11,949 Reduced 33.33% |
$1,858,189
$155.51 p/Share
|
May 16
2017 |
|
RARX
|
Novartis Bioventures LTD
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 20,081 Reduced 0.82% |
$528,733
$26.33 p/Share
|
May 16
2017 |
|
MDC
|
Michael A Berman
Director |
SELL
Open market or private sale
|
Direct | 52,500 Reduced 76.92% |
$1,869,000
$35.6 p/Share
|
May 15
2017 |
|
ORCL
|
Hector Garcia Molina
Director |
SELL
Open market or private sale
|
Direct | 3,750 Reduced 36.92% |
$169,688
$45.25 p/Share
|
May 15
2017 |
|
MDC
|
David E Blackford
Director |
SELL
Open market or private sale
|
Direct | 27,050 Reduced 72.27% |
$964,062
$35.64 p/Share
|
May 15
2017 |
|
EA
|
Joel Linzner
EVP Worldwide Business Affairs |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 37.39% |
$1,003,400
$100.34 p/Share
|
May 15
2017 |
|
KWR
|
L Wilbert Platzer
SVP, Global Ops, EHS & Prcmt |
SELL
Open market or private sale
|
Direct | 5,621 Reduced 45.22% |
$789,694
$140.49 p/Share
|
May 15
2017 |
|
TXN
|
Darla H Whitaker
Sr. Vice President |
SELL
Open market or private sale
|
Direct | 60,626 Reduced 43.47% |
$4,922,831
$81.2 p/Share
|
May 15
2017 |
|
FCNCA
|
Robert R Hoppe
Director |
BUY
Open market or private purchase
|
Direct | 19 Added 9.13% |
$6,524
$343.38 p/Share
|
May 15
2017 |
|
LSXMA
|
Berkshire Hathaway Inc |
BUY
Open market or private purchase
|
Indirect | 971,623 Added 3.33% |
$35,444,807
$36.48 p/Share
|
May 15
2017 |
|
LSXMA
|
Berkshire Hathaway Inc |
BUY
Open market or private purchase
|
Indirect | 265,606 Added 1.94% |
$9,745,084
$36.69 p/Share
|
May 15
2017 |
|
SFNC
|
George Makris Jr
Chairman & CEO |
BUY
Open market or private purchase
|
Direct | 2,000 Added 1.91% |
$104,000
$52.0 p/Share
|
May 12
2017 |
|
STKL
|
Oaktree Huntington Investment Fund Ii, L.P.
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 644,540 Added 32.18% |
$4,834,050
$7.5 p/Share
|
May 12
2017 |
|
AMKR
|
Gil C. Tily
Director |
SELL
Open market or private sale
|
Direct | 41,822 Reduced 38.67% |
$488,481
$11.68 p/Share
|
May 12
2017 |
|
MRK
|
C Robert Kidder
Director |
SELL
Open market or private sale
|
Direct | 5,000 Reduced 34.92% |
$317,700
$63.54 p/Share
|
May 12
2017 |
|
AMKR
|
Winston J Churchill
Director |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 25.79% |
$118,100
$11.81 p/Share
|
May 12
2017 |
|
IDCC
|
Lawrence F Shay
SEVP,Fut.Wireless,&Ch.IPCouns. |
SELL
Open market or private sale
|
Direct | 8,000 Reduced 14.25% |
$689,440
$86.18 p/Share
|
May 12
2017 |